Keywords: s-p, sugammadex, nda, gets, priority, status, drug

S-P's sugammadex NDA gets priority status

Article | 14 January 2008

Print This

US drug major Schering-Plough says that the Food and Drug Administration has assigned priority review status to the company's New ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in